Form 8-K - Current report:
SEC Accession No. 0000950123-11-037797
Filing Date
2011-04-21
Accepted
2011-04-21 15:58:11
Documents
5
Period of Report
2011-04-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c15823e8vk.htm 8-K 15000
2 EXHIBIT 99.1 c15823exv99w1.htm EX-99.1 3066
3 GRAPHIC c15823c1582301.gif GRAPHIC 9798
4 GRAPHIC c15823c1582302.gif GRAPHIC 3681
5 GRAPHIC c15823c1582303.gif GRAPHIC 7981
  Complete submission text file 0000950123-11-037797.txt   49336
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 11773502
SIC: 2834 Pharmaceutical Preparations